A personalised vaccine for the aggressive and fatal brain cancer glioblastoma has shown encouraging signs of efficacy in its first human trial. The vaccine – developed by researchers at the ...

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma. Following the results of a hypothesis-generating study of immunotherapy in ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Glioblastoma multiforme (GBM) is the most ...

Get Instant Summarized Text (Gist) Cell death, or necrosis, is identified as a driving force in glioblastoma progression, rather than just a byproduct of aggressive tumor growth. Research using ...

A whole-body MRI scan revealed multifocal lesions in both lower limb bones, and the biopsy confirmed the lesions to be epithelioid haemangioma. Because of the multifocal involvement, the child ...

Brain cancer might not be as prevalent as breast cancer, prostate cancer, or lung cancer, but one type of brain cancer, glioblastoma, comes with a poor prognosis. According to the Mayo Clinic ...

Drug concentration in non–contrast-enhancing brain regions in humans measured directly or indirectly. A 2022 analysis of genotypically targeted drugs against glioblastoma found that CNS drug selection ...

Among patients with recurrent glioblastoma (GBM), the combination of VXM01, an investigational oral anti–VEGFR-2 vaccine, and the PD-L1 inhibitor avelumab (Bavencio) was generally well tolerated, with ...

An Instagram reel claims that Nicotine cures glioblastoma tumors in less than 72 hours. The claim by the user is FALSE. In an Instagram reel, it is claimed that Nicotine cures glioblastoma tumors in ...